TELA Bio is a life science company that specializes in soft tissue reconstruction.
TELA Bio has raised $60.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in November 2025.
TELA Bio's investors include Perceptive Advisors, OrbiMed, MidCap Financial, EW Healthcare Partners, Pacira Pharmaceuticals.
TELA Bio is headquartered in Malvern, United States.
TELA Bio is a life science company that specializes in soft tissue reconstruction.
TELA Bio is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TELA Bio — Funding & Investors." VCBacked, November 13, 2025, https://www.vcbacked.co/company/tela-bio. Accessed September 29, 2026.
VCBacked. (2025). TELA Bio — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/tela-bio
{{cite web |title=TELA Bio — Funding & Investors |url=https://www.vcbacked.co/company/tela-bio |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated